Robert Truckenmiller

Senior Vice President of Market Access & Customer Solutions


Profile

Robert Truckenmiller is Senior Vice President of Market Access & Customer Solutions at EMD Serono.

In this role, he oversees the development of U.S. market access strategies and implementation, as well as payer contracting and reimbursement strategies, to enable patient access to EMD Serono medications.

Prior to EMD Serono, Rob served as Vice President and Head of U.S. Market Access & Pricing at UCB, where he led a large team in developing a market access strategy that successfully improved overall patient access to UCB brands. He spent eleven years at UCB, taking on roles of increasing responsibility across market access and brand marketing.

Rob has more than 15 years of experience in the biopharmaceutical industry in various sales and marketing roles at companies such as Johnson & Johnson and DaVita Kidney Care. Additionally, Rob is a six-year veteran of the U.S. Coast Guard.

Rob holds an undergraduate degree in Marketing and an MBA in Finance and Financial Management Services from University of Central Florida - College of Business Administration.  

Redirect

You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement